UPMC Grand Rounds: POS Guest Speaker

Controversies in Proliferative Vitreoretinopathy

 

 

Dr. Eliott is Associate Director of the Retina Service and the Stelios Evangelos Gragoudas Associate Professor of Ophthalmology at the Massachusetts Eye and Ear Infirmary and Harvard Medical School.
 
Dr. Eliott attended Duke University for college, and he received his medical degree with honors from Vanderbilt University School of Medicine. He completed his residency at the Wilmer Eye Institute, Johns Hopkins Hospital, and he received his vitreoretinal fellowship training at the Duke Eye Center, Duke University Medical Center. He then served as the Chief Resident and vitreoretinal faculty member at the Duke Eye Center. 
 
Following this, Dr. Eliott was the Director of the Retina Service, Associate Professor, and Vitreoretinal Fellowship Director at the Kresge Eye Institute of Wayne State University School of Medicine. Subsequently, he was the Director of the Doheny Retina Institute, Professor, and Vitreoretinal Fellowship Director at the Doheny Eye Institute and the University of Southern California Keck School of Medicine.
 
Dr. Eliott is currently the Director of the Retina Fellowship at Mass. Eye & Ear / Harvard. He received numerous teaching awards, including the Crystal Apple Award from the American Society of Retina Specialists and the Lifetime Mentor Award from the Vit-Buckle Society.  He participates in all of the major annual fellowship teaching conferences, including the Mass. Eye & Ear Vitrectomy course, Fellows’ Forum, the Duke Vitrectomy Course, and the Transitions into Clinical Practice Course. He has been a principal investigator for many clinical trials, including the Argus II retinal prosthesis, stem cell-derived retinal pigment epithelial cell transplants, stem cell-derived retinal progenitor cell transplants, and gene therapy studies. He is on the editorial board for several journals, and he has over 150 publications in ophthalmic journals and textbooks. Dr. Eliott has special interest in diabetic retinopathy, retinal detachment, trauma, and surgery for complex retina-vitreous disorders.